Intellectual Property Appellate Board directs Apple Inc to respond on trademark issueThe directive was issued by IPAB here on the rectification petition filed by Erode-based iVoice, engaged in intellectual property rights an...
Bayer challenges IPAB’s compulsory licence order to Natco Pharma on cancer drug Nexavar“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said...
Britannia can’t register biscuit brand 'Snax' as a trademarkThe IPAB, India’s patent appeals board, on Monday ruled that the Snax biscuit brand of Britannia Industries cannot be trademarked.
- Intellectual board upholds CL to Natco for cancer drug
The IPAB has upheld the compulsory licence issued to Natco Pharma for production and marketing of generic version of cancer drug Nexavar.
- IPAB set to decide on 16-yr-old dispute over the brand name Original Choice
The producers of Officer’s Choice whisky had challenged the use of the brand name that sounds and looks similar to its name.
- Bayer says it will defend its intellectual property rights on cancer drug
Bayer today said it will continue to defend its IP rights while expressing disappointment at the IPAB decision to reject the firm's plea to...
- RIL in trademark tussle over 'Reliance'
A Surat-based bag maker is fighting a trademark battle with Reliance Industries Ltd insisting that he be allowed to retain the brand name.
- IPAB centre likely to come up in Mumbai, Delhi and Kolkata
The government may need to set up permanent centres of the country’s nodal body monitoring disputes related to intellectual property rights...
- Writ petition says IP tribunal incompetent
A group of patent lawyers have filed a writ petition challenging the legality of the country's highest technical body for intellectual prop...
- SC sets aside tribunal order on Infosys trademark
The SC set aside the Intellectual Property Appellate Board''s decision to turn down Infosys' claim to exclusive ownership of the trademark ...
- Novartis to challenge IPAB’s patent decision on Glivec
The Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board (IPAB) that said i...
- Madras HC stays appellate board order on dual-SIM patent
The Madras High Court set aside an interim order passed by the Intellectual Property Appellate Board (IPAB), suspending the patent held by ...
- Novartis appeal excludes technical member
The Union Government today informed the Madras High Court that the Intellectual Property Appellate Board (IPAB) could exclude technical mem...
- HC suspends hearings in Novartis' Glivec case
Hearings in Novartis’ appeal against the rejection of patent for its anti-cancer drug Glivec have been suspended yet again, after the Madra...
- Novartis not to plead Glivec case
Novartis moves to Madras HC seeking removal of former patent chief from IPAB.
- Setback for Novartis as Chandrasekaran stays
The Indian Patent Appellate Board dismisses Novartis' objection to the appointment of S Chandrasekaran.
- IPAB hears Novartis’ objection against S Chandrasekaran
The Indian Patent Appellate Board (IPAB) on Monday heard a case that will decide whether S Chandrasekaran, former controller general of pat...